Evidence Level:Sensitive: D – Preclinical
New
Title:
Inhibitory Effects of the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 on the Proliferation and Tumor Growth of Thyroid Cancer Cells with BRAF or RAS Mutations
Excerpt:Genotypes of various thyroid cancer cell lines and their sensitivity to inhibition by CI-1040.
DOI:https://doi.org/10.1210/jc.2007-0097